Avanos Medical, Inc.
AVNS · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $1 | $1 | $1 | $2 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $1 | $1 | $1 | $2 |
| Revenue | $1 | $1 | $1 | $1 |
| % Growth | 2.2% | -1.6% | -8.1% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 55.4% | 56.4% | 57.6% | 51% |
| EBITDA | -$0 | $0 | $0 | $0 |
| % Margin | -50.2% | 7.5% | 11.4% | 6.6% |
| Net Income | -$0 | -$0 | $0 | $0 |
| % Margin | -57% | -9.2% | 7.4% | 0.8% |
| EPS Diluted | -8.53 | -1.33 | 1.07 | 0.13 |
| % Growth | -541.4% | -224.3% | 723.1% | – |
| Operating Cash Flow | $0 | $0 | $0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | $0 | $0 | $0 |